Lava Therapeutics Nv's ROA from the third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Lava Therapeutics Nv's ROA in the third quarter of 2025?
Lava Therapeutics Nv recorded a cumulative net loss of $-23 million during 12 months ending in the third quarter of 2025, resulting in a negative return on assets (ROA) of -20.3%.

However, within the Healthcare sector Lava Therapeutics Nv achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the second quarter of 2025 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Total Assets Change	-44.16 %	-31.4 %	20.1 %	829.53 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-23	-28	-28	-25	-21
Return On Assets (TTM)	-20.3 %	-21.09 %	-19.4 %	-17.99 %	-20.32 %
LVTX's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	102	87	111	157	182
Seq. Total Assets Change	16.86 %	-21.57 %	-29.55 %	-13.51 %	43.54 %
Seq. Net Income Change	-	-	-	-	-

LVTX's 5 Years Annual ROA >> Back to LVTX Management Effectiveness >> Compare LVTX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Lava Therapeutics Nv's Assets	$ 102 million	LVTX's Balance sheet
Lava Therapeutics Nv's Income	$ -7 million	Quarterly LVTX's Income Statement
LVTX's Income by Division		See LVTX's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2020) FY 2021	FY
Y / Y Total Assets Change	-33.38 %	40.26 %	20.96 %	-	-
Total Assets in million	157	236	168	139	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-25	-42	-32	-42	0
Annual Return On Assets	-15.96 %	-17.72 %	-18.94 %	-30.42 %	-

LVTX's 5 Years Annual ROA >> Back to LVTX Management Effectiveness >> Compare LVTX ROA to its Competitors

More Return On Assets Ratios
LVTX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
LVTX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for LVTX's Competitors
Subscribers only: Roa for Lava Therapeutics Nv's Suppliers
Subscribers only: Return On Assets for LVTX's Customers

You may also want to know
LVTX's Roi	LVTX's Inventory Turnover Ratio	LVTX's Growth Rates	LVTX's Dividend Comparisons
	LVTX's Profitability Ratios	LVTX's Asset Turnover Ratio	LVTX's Dividend Growth
LVTX's Roe	LVTX's Valuation Ratios	LVTX's Financial Strength Ratios	LVTX's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2025, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:43:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.